Publications

2023

  • A motion model-guided 4D dose reconstruction for pencil beam scanned proton therapy Duetschler A, Huang L, Fattori G, et al.
    Phys Med Biol (2023).
    DOI: 10.1088/1361-6560/acd518
  • Technical note: Towards more realistic 4DCT(MRI) numerical lung phantoms Jenny T, Duetschler A, Giger A, et al.
    Med Phys (2023).
    DOI: 10.1002/mp.16451
  • In situ correction of recombination effects in ultra-high dose rate irradiations with protons Schaefer R, Psoroulas S, Weber DC, et al.
    Phys Med Biol (2023).
    DOI: 10.1088/1361-6560/accf5c
  • Inter- and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer Smolders S, Hengeveld AC, Both S, et al.
    Radiother Oncol (2023).
    DOI: 10.1016/j.radonc.2023.109488 DORA PSI
  • Patient-specific neural networks for contour propagation in online adaptive radiotherapy Smolders A, Lomax A, Weber DC, et al.
    Phys Med Biol (2023).
    DOI: 10.1088/1361-6560/accaca DORA PSI
  • Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands Walser M, Bachmann N, Kluckert J, et al.
    Br J Radiol (2023).
    DOI: 10.1259/bjr.20220672
  • A survey of practice patterns for real-time intrafractional motion-management in particle therapy Zhang Y, Trnkova P, Toshito T, et al.
    Phys Imaging Radiat Oncol (2023).
    DOI: 10.1016/j.phro.2023.100439 DORA PSI

2022

  • Combined proton-photon therapy for non-small cell lung cancer Amstutz F, Fabiano S, Marc L, et al.
    Med Phys (2022).
    DOI: 10.1002/mp.15715
  • Clinical Outcome After Pencil Beam Scanning Proton Therapy of Patients With Non-Metastatic Malignant and Benign Peripheral Nerve Sheath Tumors Bachmann N, Leiser D, Pica A, et al.
    Front Oncol (2022).
    DOI: 10.3389/fonc.2022.881665
  • Hearing Loss in Cancer Patients with Skull Base Tumors Undergoing Pencil Beam Scanning Proton Therapy: A Retrospective Cohort Study Bachtiary B, Veraguth D, Roos N, et al.
    Cancers (2022).
    DOI: 10.3390/cancers14163853
  • Impact of spot reduction on the effectiveness of rescanning in pencil beam scanned proton therapy for mobile tumours Bertschi S, Krieger M, Weber DC, et al.
    Phys Med Biol (2022).
    DOI: 10.1088/1361-6560/ac96c5 DORA PSI
  • Improved simultaneous LET and dose measurements in proton therapy Christensen JB, Togno M, Bossin L, et al.
    Sci Rep (2022).
    DOI: 10.1038/s41598-022-10575-4
  • Synthetic 4DCT(MRI) lung phantom generation for 4D radiotherapy and image guidance investigations Duetschler A, Baumann G, Bieri O, et al.
    Med Phys (2022).
    DOI: 10.1002/mp.15591 DORA PSI
  • Limitations of phase-sorting based pencil beam scanned 4D proton dose calculations under irregular motion Duetschler A, Prendi J, Safai S, et al.
    Phys Med Biol (2022).
    DOI: 10.1088/1361-6560/aca9b6 DORA PSI
  • Commissioning and quality assurance of a novel solution for respiratory-gated PBS proton therapy based on optical tracking of surface markers Fattori G, Hrbacek J, Regele H, et al.
    Z Med Phys (2022).
    DOI: 10.1016/j.zemedi.2020.07.001
  • Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy Gerken LRH, Gogos A, Starsich FHL, et al.
    Nature Commun (2022).
    DOI: 10.1038/s41467-022-30982-5
  • Beam properties within the momentum acceptance of a clinical gantry beamline for proton therapy Giovannelli AC, Maradia V, Meer D, et al.
    Med Phys (2022).
    DOI: 10.1002/mp.15449
  • Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres Hoffmann L, Mortensen H, Shamshad M, et al.
    Radiother Oncol (2022).
    DOI: 10.1016/j.radonc.2022.04.029
  • Comparing radiolytic production of H2 O2 and development of Zebrafish embryos after ultra high dose rate exposure with electron and transmission proton beams Kacem H, Psoroulas S, Boivin G, et al.
    Radiother Oncol (2022).
    DOI: 10.1016/j.radonc.2022.07.011
  • The impact of organ motion and the appliance of mitigation strategies on the effectiveness of hypoxia-guided proton therapy for non-small cell lung cancer Köthe A, Lomax AJ, Giovannelli AC, et al.
    Radiother Oncol (2022).
    DOI: 10.1016/j.radonc.2022.09.021 DORA PSI
  • A quantitative FLASH effectiveness model to reveal potentials and pitfalls of high dose rate proton therapy Krieger M, van de Water S, Volkerts MM, et al.
    Med Phys (2022).
    DOI: 10.1002/mp.15459
  • Increase of the transmission and emittance acceptance through a cyclotron-based proton therapy gantry Maradia V, Giovannelli AC, Meer D, et al.
    Med Phys (2022).
    DOI: 10.1002/mp.15505
  • Ultra-fast pencil beam scanning proton therapy for locally advanced non-small-cell lung cancers: Field delivery within a single breath-hold Maradia V, van de Water S, Meer D, et al.
    Radiother Oncol (2022).
    DOI: 10.1016/j.radonc.2022.06.018
  • Universal and dynamic ridge filter for pencil beam scanning particle therapy: a novel concept for ultra-fast treatment delivery Maradia V, Colizzi I, Meer D, et al.
    Phys Med Biol (2022).
    DOI: 10.1088/1361-6560/ac9d1f
  • GPU accelerated Monte Carlo scoring of positron emitting isotopes produced during proton therapy for PET verification McNamara K, Schiavi A, Borys D, et al.
    Phys Med Biol (2022).
    DOI: 10.1088/1361-6560/aca515
  • Low-Dose Computed Tomography Scanning Protocols for Online Adaptive Proton Therapy of Head-and-Neck Cancers Nesteruk KP, Bobic M, Sharp GC et al.
    Cancers (2022).
    DOI: 10.3390/cancers14205155 DORA PSI
  • NTCP modelling for high-grade temporal radionecrosis in a large cohort of patients receiving pencil beam scanning proton therapy for skull base and head and neck tumors Schroeder C, Koethe A, de Angelis C, et al.
    Int J Radiat Oncol Biol Phys (2022).
    DOI: 10.1016/j.ijrobp.2022.01.047
  • Ultra-high dose rate dosimetry for pre-clinical experiments with mm-small proton fields Togno M, Nesteruk KP, Schaefer R, et al.
    Phys Med (2022).
    DOI: 10.1016/j.ejmp.2022.10.019 DORA PSI
  • Early outcome after craniospinal irradiation with pencil beam scanning proton therapy for children, adolescents and young adults with brain tumors Vazquez M, Bachmann N, Pica, A, et al.
    Pediatr Blood Cancer (2022).
    DOI: 10.1002/pbc.30087
  • MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy Via R, Pica A, Antonioli L, et al.
    Radiother Oncol (2022).
    DOI: 10.1016/j.radonc.2022.06.021
  • Quality-of-life evaluations in children and adolescents with Ewing sarcoma treated with pencil-beam-scanning proton therapy Weber DC, Beer J, Kliebsch UL, et al.
    Pediatr Blood Cancer (2022).
    DOI: 10.1002/pbc.29956

2021

  • An approach for estimating dosimetric uncertainties in deformable dose accumulation in pencil beam scanning proton therapy for lung cancer Amstutz F, Nenoff L, Albertini F, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/abf8f5 DORA PSI
  • Al2O3:C optically stimulated luminescence dosimeters (OSLDs) for ultra-high dose rate proton dosimetry Christensen JB, Togno M, Nesteruk K, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/abe554 DORA PSI
  • Enhanced Deep-Inspiration Breath Hold Superior to High-Frequency Percussive Ventilation for Respiratory Motion Mitigation: A Physiology-Driven, MRI-Guided Assessment Toward Optimized Lung Cancer Treatment With Proton Therapy Emert F, Missimer J, Eichenberger PA, et al.
    Front Oncol (2021).
    DOI: 10.3389/fonc.2021.621350 DORA PSI
  • Combining rescanning and gating for a time-efficient treatment of mobile tumors using pencil beam scanning proton therapy Gut P, Krieger M, Lomax T, et al.
    Radiother Oncol (2021).
    DOI: 10.1016/j.radonc.2021.03.041 DORA PSI
  • Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer Köthe A, Bizzocchi N, Safai S, et al.
    Radiat Oncol (2021).
    DOI: 10.1186/s13014-021-01914-2Link to the podcast
  • Combining clinical and dosimetric features in a PBS proton therapy cohort to develop a NTCP model for radiation-induced optic neuropathy Köthe A, van Luijk P, Safai S, et al.
    Int J Rad Oncol Biol Phys (2021).
    DOI: 10.1016/j.ijrobp.2020.12.052 DORA PSI
  • Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy Köthe A, Feuvret L, Weber DC, et al.
    Cancers (2021).
    DOI: 10.3390/cancers13215327 DORA PSI
  • A Prospective Study on Health-Related Quality of Life and Patient-Reported Outcomes in Adult Brain Tumor Patients Treated with Pencil Beam Scanning Proton Therapy Kroeze SGC, Mackeprang PH, De Angelis C, et al.
    Cancers (2021).
    DOI: 10.3390/cancers13194892
  • A new emittance selection system to maximize beam transmission for low-energy beams in cyclotron-based proton therapy facilities with gantry Maradia V, Meer D, Weber DC, et al.
    Med Phys (2021).
    DOI: 10.1002/mp.15278
  • Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy Marinkovic M, Pors LJ, van den Berg V, et al.
    Cancers (2021).
    DOI: 10.3390/cancers13246241
  • Dosimetric influence of deformable image registration uncertainties on propagated structures for online daily adaptive proton therapy of lung cancer patients Nenoff L, Matter M, Amaya EJ, et al.
    Radiother Oncol (2021).
    DOI: 10.1016/j.radonc.2021.03.021
  • Experimental validation of daily adaptive proton therapy Nenoff L, Matter M, Charmillot M, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/ac2b84Link to the podcast
  • A static beam delivery device for fast scanning proton arc-therapy Nesteruk KP, Bolsi A, Lomax AJ, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/abe02b DORA PSI
  • FLASH Irradiation with Proton Beams: Beam Characteristics and Their Implications for Beam Diagnostics Nesteruk KP, Psoroulas S.
    Applied Sciences (2021).
    DOI: 10.3390/app11052170
  • Commissioning of a clinical pencil beam scanning proton therapy unit for ultra-high dose rates (FLASH) Nesteruk KP, Togno M, Grossmann M, et al.
    Med Phys (2021).
    DOI: 10.1002/mp.14933 DORA PSI
  • CT-on-Rails Versus In-Room CBCT for Online Daily Adaptive Proton Therapy of Head-and-Neck Cancers Nesteruk KP, Bobic M, Lalonde A, et al.
    Cancers (2021).
    DOI: 10.3390/cancers13235991
  • Roadmap: proton therapy physics and biology Paganetti H, Beltran C, Both S, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/abcd16
  • Non-invasive recognition of eye torsion through optical imaging of the iris pattern in ocular proton therapy Spaccapaniccia C, Via R, Thominet V, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/ac0afb
  • Effects of deep inspiration breath hold on prone photon or proton irradiation of breast and regional lymph nodes Speleers B, Schoepen M, Belosi F, et al.
    Sci Rep (2021).
    DOI: 10.1038/s41598-021-85401-4
  • Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy Walser M, Bojaxhiu B, Kawashiro S, et al.
    Clin Oncol (2021).
    DOI: 10.1016/j.clon.2021.07.012
  • Faraday cup for commissioning and quality assurance for proton pencil beam scanning beams at conventional and ultra-high dose rates Winterhalter C, Togno M, Nesteruk KP, et al.
    Phys Med Biol (2021).
    DOI: 10.1088/1361-6560/abfbf2 DORA PSI

2020

  • Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy Basler L, Poel R, Schröder C, et al.
    Radiat Oncol (2020).
    DOI: 10.1186/s13014-020-01711-3
  • Outcomes, Prognostic Factors and Salvage Treatment for Recurrent Chordoma After Pencil Beam Scanning Proton Therapy at the Paul Scherrer Institute Beer J, Kountouri M, Kole AJ, et al.
    Clin Oncol (2020).
    DOI: 10.1016/j.clon.2020.03.002
  • Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: a dosimetric and linear energy transfer (LET) evaluation Bolsi A, Placidi L, Pica A, et al.
    Radiother Oncol (2020).
    DOI: 10.1016/j.radonc.2020.04.052
  • Anthropomorphic phantom for deformable lung and liver CT and MR imaging for radiotherapy Colvill E, Krieger M, Bosshard P, et al.
    Phys Med Biol (2020).
    DOI: 10.1088/1361-6560/ab7508
  • Role of Complex Networks for Integrating Medical Images and Radiomic Features of Intracranial Ependymoma Patients in Response to Proton Radiotherapy Dominietto M, Pica A, Safai S, et al.
    Front Med (Lausanne) (2020).
    DOI: 10.3389/fmed.2019.00333
  • The potential of Gantry beamline large momentum acceptance for real time tumour tracking in pencil beam scanning proton therapy Fattori G, Zhang Y, Meer D, et al.
    Sci Rep (2020).
    DOI: 10.1038/s41598-020-71821-1
  • Commissioning and Quality Assurance of a novel solution for respiratory-gated PBS proton therapy based on optical tracking of surface markers Fattori G, Hrbacek J, Regele H, et al.
    Z Med Phys (2020).
    DOI: 10.1016/j.zemedi.2020.07.001
  • Liver-ultrasound based motion modelling to estimate 4D dose distributions for lung tumours in scanned proton therapy Giger AT, Krieger M, Jud C, et al.
    Phys Med Biol (2020).
    DOI: 10.1088/1361-6560/abaa26
  • Prognostic impact of the “Sekhar grading system for cranial Chordomas” in patients treated with pencil beam scanning proton therapy: an institutional analysis Hottinger AL, Bojaxhiu B, Ahlhelm F, et al.
    Radiat Oncol (2020).
    DOI: 10.1186/s13014-020-01547-x
  • Impact of internal target volume definition for pencil beam scanned proton treatment planning in the presence of respiratory motion variability for lung cancer: A proof of concept Krieger M, Giger A, Salomir R, et al.
    Radiother Oncol (2020).
    DOI: 10.1016/j.radonc.2019.12.001
  • Liver-ultrasound-guided lung tumour tracking for scanned proton therapy: a feasibility study Krieger M, Giger A, Jud C, et al.
    Phys Med Biol (2020).
    DOI: 10.1088/1361-6560/abcde6
  • Pencil Beam Scanning Proton Therapy for Paediatric Neuroblastoma with Motion Mitigation Strategy for Moving Target Volumes Lim PS, Pica A, Hrbacek J, et al.
    Cin Oncol (2020).
    DOI: 10.1016/j.clon.2020.02.002
  • Outcomes of adolescents and young adults treated for brain and skull base tumors with pencil beam scanning proton therapy Lim PS, Tran S, Kroeze SGC, et al.
    Pediatr Blood Cancer (2020).
    DOI: 10.1002/pbc.28664
  • Update on yesterday's dose - use of delivery log-files for daily adaptive proton therapy (DAPT) Matter M, Nenoff L, Marc L, et al.
    Phys Med Biol (2020).
    DOI: 10.1088/1361-6560/ab9f5e
  • Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience Mishra KK, Afshar A, Thariat J, et al.
    Adv Radiat Oncol (2020).
    DOI: 10.1016/j.adro.2020.04.010
  • Prognostic factors for spinal chordomas and chondrosarcomas treated with postoperative pencil-beam scanning proton therapy: a large, single-institution experience Murray FR, Snider JW, Schneider RA, et al.
    J Neurosurg Spine (2020).
    DOI: 10.3171/2019.11.SPINE1927
  • Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy Nenoff L, Ribeiro CO, Matter M, et al.
    Radiother Oncol (2020).
    DOI: 10.1016/j.radonc.2020.04.046
  • Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption? Nenoff L, Matter M, Jarhall AG, et al.
    Int J Rad Onc Biol Phys (2020).
    DOI: 10.1016/j.ijrobp.2020.03.036
  • Geometry optimisation of graphite energy degrader for proton therapy Oponowicz E, Owen HL, Psoroulas S, et al.
    Phys Med (2020).
    DOI: 10.1016/j.ejmp.2020.06.023
  • Quantification of a human reliability analysis method for radiotherapy applications based on expert judgment aggregation Pandya D, Podofillini L, Emert F, et al.
    Reliab Engin & Syst Safety (2020).
    DOI: 10.1016/j.ress.2019.05.001
  • Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy Pelak MJ, Walser M, Bachtiary, et al.
    Oral Oncol (2020).
    DOI: 10.1016/j.oraloncology.2020.104752
  • Good long-term visual outcomes of parapapillary choroidal melanoma patients treated with proton therapy: a comparative study Pica A, Weber DC, Vallat L, et al.
    Int Ophtalmol (2020).
    DOI: 10.1007/s10792-020-01594-z
  • Assessing the advantages of CFR-PEEK over titanium spinal stabilization implants in proton therapy - a phantom study Poel R, Belosi MF, Albertini F, et al.
    Phys Med Biol (2020).
    DOI: 10.1088/1361-6560/ab8ba0
  • Mean excitation energy determination for Monte Carlo simulations of boron carbide as degrader material for proton therapy Psoroulas S, Meer, D, Oponowicz E, et al.
    Phys Med (2020).
    DOI: 10.1016/j.ejmp.2020.09.017
  • Benchmarking a commercial proton therapy solution: The Paul Scherrer institut experience Rosas S, Belosi FM, Bizzocchi N, et al.
    Br J Radiol (2020).
    DOI: 10.1259/bjr.20190920
  • Clinical outcomes and quality of life in children and adolescents with primary brain tumors treated with pencil beam scanning proton therapy Tran S, Lim PS, Bojaxhiu B, et al.
    Pediatr Blood Cancer (2020).
    DOI: 10.1002/pbc.28465
  • Shortening delivery times for intensity-modulated proton therapy by reducing the number of proton spots: an experimental verification Van de Water S, Belosi FM, Albertini F, et al.
    Phys Med Biol (2020).
    DOI: 10.1088/1361-6560/ab7e7c
  • Technical Note: Benchmarking automated eye tracking and human detection for motion monitoring in ocular proton therapy Via R, Hennings F, Fattori G, et al.
    Med Phys (2020).
    DOI: 10.1002/mp.14087
  • Potential and pitfalls of 1.5 T MRI imaging for target volume definition in ocular proton therapy Via R, Hennings F, Pica A, et al.
    Radiother Oncol (2020).
    DOI: 10.1016/j.radonc.2020.08.023
  • Proton therapy and the European Particle Therapy Network: The past, present and future Weber DC, Langendijk JA, Grau C, et al.
    Cancer Radiother (2020).
    DOI: 10.1016/j.canrad.2020.05.002
  • Proton Therapy for Intracranial Meningioma for the Treatment of Primary/Recurrent Disease Including Re-Irradiation Weber DC, Bizzocchi N, Bolsi A, et al.
    Front Oncol (2020).
    DOI: 10.3389/fonc.2020.558845
  • Pitfalls in the beam modelling process of Monte Carlo calculations for proton pencil beam scanning Winterhalter C, Aitkenhead A, Oxley D, et al.
    Br J Radiol (2020).
    DOI: 10.1259/bjr.20190919

2016-2019

  • Precise beam delivery for proton therapy with dynamic energy modulation Actis O, Mayor A, Meer D, et al.
    J Phys (2018).
    DOI: 10.1088/1742-6596/1067/9/092002
  • A comprehensive and efficient daily quality assurance for PBS proton therapy Actis O, Meer D, König S, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa5131
  • Online daily adaptive proton therapy Albertini F, Matter M, Nenoff L, et al.
    Br J Radiol (2019).
    DOI: 10.1259/bjr.20190594
  • Pencil beam scanning proton therapy for pediatric intracranial ependymoma Ares C, Albertini F, Frei-Welte M, et al.
    Neuro-Oncol (2016).
    DOI: 10.1007/s11060-016-2090-4
  • Clinical and Radiologic Outcomes in Adults and Children Treated with Pencil-Beam Scanning Proton Therapy for Low-Grade Glioma Badiyan S, Ulmer S, Ahlhelm FJ, et al.
    Int J Particle Ther (2017).
    DOI: 10.14338/IJPT-16-00031.1
  • Treatment log files as a tool to identify treatment plan sensitivity to inaccuracies in scanned proton beam delivery Belosi MF, van der Meer R, Garcia de Acilu Laa P, et al.
    Radiother Oncol (2017).
    DOI: 10.1016/j.radonc.2017.09.037
  • Advanced treatment planning using direct 4D optimisation for pencil-beam scanned particle therapy Bernatowicz K, Zhang Y, Perrin RL, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa7ab8
  • Four-Dimensional Dose Reconstruction for Scanned Proton Therapy Using Liver 4DCT-MRI Bernatowicz K, Peroni M, Perrin R, et al.
    Int J Rad Onc Biol Phys (2016).
    DOI: 10.1016/j.ijrobp.2016.02.050
  • Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy Bojaxhiu B, Ahlhelm F, Walser M, et al.
    Int J Rad Onc Biol Phys (2018).
    DOI: 10.1016/j.ijrobp.2017.11.037
  • Dynamic beam current control for improved dose accuracy in PBS proton therapy Bula C, Belosi MF, Eichin M, et al.
    Phys Med Biol Phys (2019).
    DOI: 10.1088/1361-6560/ab3317
  • Whole-ventricular irradiation for intracranial germ cell tumors: Dosimetric comparison of pencil beam scanned protons, intensity-modulated radiotherapy and volumetric-modulated arc therapy Correia D, Terribilini D, Zepter S, et al.
    Clin Transl Radiat Oncol (2019).
    DOI: 10.1016/j.ctro.2019.01.002
  • Proton Irradiation with Hyperthermia in Unresectable Soft Tissue Sarcoma Datta NR, Schneider R, Puric E, et al.
    Int J Particle Ther (2016).
    DOI: 10.14338/IJPT-16-00016.1
  • 4Comparing the effectiveness and efficiency of various gating approaches for PBS proton therapy of pancreatic cancer using 4D-MRI datasets Dolde K, Naumann P, David C, et al.
    Phys Med Biol (2019).
    DOI: 10.1088/1361-6560/ab1175
  • 4DMRI-based investigation on the interplay effect for pencil beam scanning proton therapy of pancreatic cancer patients Dolde K, Zhang Y, Chaudhri N, et al.
    Radiat Oncol (2019).
    DOI: 10.1186/s13014-019-1231-2
  • 4D dose calculation for pencil beam scanning proton therapy of pancreatic cancer using repeated 4DMRI datasets Dolde K, Naumann P, David C, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aad43f
  • Robustness of the Voluntary Breath-Hold Approach for the Treatment of Peripheral Lung Tumors Using Hypofractionated Pencil Beam Scanning Proton Therapy Dueck J, Knopf A, Lomax A, et al.
    Int J Rad Onc Biol Phys (2016).
    DOI: 10.1016/j.ijrobp.2015.11.015
  • The Simulated Effect of the Breath-Hold Reproducibility Treating Locally-Advanced Lung Cancer with Pencil Beam Scanned Proton Therapy Dueck J, Perrin R, Persson GF, et al.
    Med Phys (2016).
    DOI: 10.1118/1.4956259
  • Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa) Ehrbar S, Perrin R, Peroni M, et al.
    Radiother Oncol (2016).
    DOI: 10.1016/j.radonc.2016.10.011
  • The dependence of interplay effects on the field scan direction in PBS proton therapy Fattori G, Klimpki G, Hrbacek J, et al.
    Phys Med Biol (2019).
    DOI: 10.1088/1361-6560/ab1150
  • Monitoring of breathing motion in image-guided PBS proton therapy: comparative analysis of optical and elecromagnetic technologies Fattori G, Safai S, Carmona PF, et al.
    Radiat Oncol (2017).
    DOI: 10.1186/s13014-017-0797-9
  • Preliminary Experimental Comparison of Spot- and Continuous Line Scanning with Or Without Rescanning for Gated Proton Therapy Fattori G, Klimpki G, Safai S, et al.
    Med Phys (2016).
    DOI: 10.1118/1.4958201
  • Dose–response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect? Gillmann C, Lomax AJ, Weber DC, et al.
    Radiother Oncol (2018).
    DOI: 10.1016/j.radonc.2018.01.018
  • The role of a microDiamond detector in the dosimetry of proton pencil beams Gomà C, Marinelli M, Safai S, et al.
    Z Med Phys (2016).
    DOI: 10.1016/j.zemedi.2015.08.003
  • The dosimetric effect of residual breath-hold motion in pencil beam scanned proton therapy - An experimental study Gorgisyan J, Lomax AJ, Rosenschold PMA, et al.
    Radiother Oncol (2019).
    DOI: 10.1016/j.radonc.2019.01.033
  • Impact of beam angle choice on pencil beam scanning breath-hold proton therapy for lung lesions Gorgisyan J, Perrin R, Lomax AJ, et al.
    Acta Oncol (2017).
    DOI: 10.1080/0284186X.2017.1287950
  • Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer Gorgisyan J, Munck Af Rosenschold P, Perrin R, et al.
    Int J Rad Onc Biol Phys (2017).
    DOI: 10.1016/j.ijrobp.2017.08.023
  • Patient positioning verification for proton therapy using proton range probes: experimental validation in phantom geometries Hammi A, Koenig S, Weber DC, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aadf79
  • Positioning of head and neck patients for proton therapy using proton range probes: a proof of concept study Hammi A, Placidi L, Weber DC, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa9cff
  • Validation Study of Proton Radiography Against CT Data for Quantitative Imaging of Anatomical Changes in Head and Neck Patients Hammi A, Weber D, Lomax A
    Med Phys (2016).
    DOI: 10.1118/1.4956109
  • Automated Treatment Planning System for Uveal Melanomas Treated With Proton Therapy: A Proof-of-Concept Analysis Hennings F, Lomax AJ, Pica A, et al.
    Int J Rad Onc Biol Phys (2018).
    DOI: 10.1016/j.ijrobp.2018.02.008
  • Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey Hrbacek J, Mishra K, Kacperek A, et al.
    Int J Rad Onc Biol Phys (2016).
    DOI: 10.1016/j.ijrobp.2016.01.040
  • The impact of pencil beam scanning techniques on the effectiveness and efficiency of rescanning moving targets Klimpki G, Zhang Y, Fattori G, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aacd27
  • A beam monitoring and validation system for continuous line scanning in proton therapy Klimpki G, Psoroulas S, Bula C, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa772e
  • Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours Kountouri M, Pica A, Walser M, et al.
    Br J Radiol (2019).
    DOI: 10.1259/bjr.20190028/aa772e
  • Experimental validation of a deforming grid 4D dose calculation for PBS proton therapy Krieger M, Klimpki G, Fattori GF, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aaad1e
  • Tumour control and Quality of Life in children with Rhabdomyosarcoma treated with pencil beam scanning Proton Therapy Leiser D, Calaminus G, Malyapa R, et al.
    Radiother Oncol (2016).
    DOI: 10.1016/j.radonc.2016.05.013
  • What will the medical physics of proton therapy look like 10 yr from now? A personal view Lomax A
    Med Phys (2018).
    DOI: 10.1002/mp.13206
  • A robust optimisation approach accounting for the effect of fractionation on setup uncertainties Lowe M, Aitkenhead A, Albertini F, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa8c58
  • Incorporating the effect of fractionation in the evaluation of proton plan robustness to setup errors Lowe M, Albertini F, Aitkenhead A, et al.
    Phys Med Biol (2016).
    DOI: 10.1088/0031-9155/61/1/413
  • Evaluation of Robustness to Setup and Range Uncertainties for Head and Neck Patients Treated With Pencil Beam Scanning Proton Therapy Malyapa R, Lowe M, Bolsi A, et al.
    Int J Rad Onc Biol Phys (2016).
    DOI: 10.1016/j.ijrobp.2016.02.016
  • Intensity modulated proton therapy plan generation in under ten seconds Matter M, Nenoff L, Meier G, et al.
    Acta Oncol (2019).
    DOI: 10.1080/0284186X.2019.1630753
  • Alternatives to patient specific verification measurements in proton therapy: a comparative experimental study with intentional errors Matter M, Nenoff L, Meier G, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aae2f4
  • Contour scanning for penumbra improvement in pencil beam scanned proton therapy Meier G, Leiser D, Besson R, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa5dde
  • Distant Subconjunctival Recurrences following Proton Therapy for a Choroidal Melanoma with Extrascleral Extension Mouvet V, Moulin A, Pica A, et al.
    Klin Monbl Augenheilkd (2019).
    DOI: 10.1055/a-0796-6299
  • Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute Mueller C, De Prado Leal M, Dominietto MD, et al.
    Pharmaceutics (2019).
    DOI: 10.3390/pharmaceutics11090450
  • Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas Murray FR, Snider JW, Bolsi A, et al.
    Int J Rad Onc Biol Phys (2017).
    DOI: 10.1016/j.ijrobp.2017.08.005
  • Daily adaptive proton therapy - the key to innovative planning approaches for paranasal cancer treatments Nenoff L, Matter M, Hedlund Lindmar J, et al.
    Acta Oncol (2019).
    DOI: 10.1080/0284186X.2019.1641217
  • Large energy acceptance gantry for proton therapy utilizing superconducting technology Nesteruk KP, Calzolaio C, Meer D, et al.
    Phys Med Biol (2019).
    DOI: 10.1088/1361-6560/ab2f5f
  • Personalized Anatomic Eye Model From T1-Weighted Volume Interpolated Gradient Echo Magnetic Resonance Imaging of Patients With Uveal Melanoma Nguyen HG, Sznitman R, Maeder P, et al.
    Int J Rad Onc Biol Phys (2018).
    DOI: 10.1016/j.ijrobp.2018.05.004
  • An anthropomorphic breating phantom for testing new motion mitigation techniques for pencil beam scanning proton therapy Perrin RL, Zakova M, Peroni M, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/62/6/2486
  • Range resolution and reproducibility of a dedicated phantom for proton PBS daily quality assurance Placidi L, Togno M, Weber DC, et al.
    Z Med Phys (2018).
    DOI: 10.1016/j.zemedi.2018.02.001
  • Effect of Anatomic Changes on Pencil Beam Scanned Proton Dose Distributions for Cranial and Extracranial Tumors Placidi L, Bolsi A, Lomax AJ, et al.
    Int J Rad Onc Biol Phys (2017).
    DOI: 10.1016/j.ijrobp.2016.11.013
  • A predictive algorithm for spot position corrections after fast energy switching in proton pencil beam scanning Psoroulas S, Bula C, Actis O, et al.
    Med Phys (2018).
    DOI: /10.1002/mp.13217
  • Assessment of dosimetric errors induced by deformable image registration methods in 4D pencil beam scanned proton treatment planning for liver tumours Ribeiro CO, Knopf A, Langendijk JA, et al.
    Radiother Oncol (2018).
    DOI: /10.1016/j.radonc.2018.03.001
  • Assessing the Quality of Proton PBS Treatment delivery using machine log files: comprehensive Analysis of clinical Treatments delivered at PSI Gantry 2 Scandurra D, Albertini F, van der Meer R, et al.
    Phys Med Biol (2016).
    DOI: 10.1088/0031-9155/61/3/1171
  • Liquid fiducial marker applicability in proton therapy of locally advanced lung cancer Scherman Rydhög J, Perrin R, Rolck RI, et al.
    Radiother Oncol (2017).
    DOI: 10.1016/j.radonc.2016.12.027
  • Can Technological Improvements Reduce the Cost of Proton Radiation Therapy? Schippers JM, Lomax A, Garonna A, et al.
    Semin Radiat Oncol (2018).
    DOI: 10.1016/j.semradonc.2017.11.007
  • Neutrons in active proton therapy: Parameterization of dose and dose equivalent Schneider U, Haelg RA, Lomax T
    Z Med Phys (2017).
    DOI: 10.1016/j.zemedi.2016.07.001
  • Long-Term Outcomes and Prognostic Factors After Pencil-Beam Scanning Proton Radiation Therapy for Spinal Chordomas: A Large, Single-Institution Cohort Snider JW, Schneider RA, Poelma-Tap D et al.
    Int J Rad Onc Biol Phys (2018).
    DOI: 10.1016/j.ijrobp.2018.01.060
  • Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain Speleers BA, Belosi FM, De Gersem WR, et al.
    Sci Rep (2019).
    DOI: 10.1038/s41598-019-41283-1
  • Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance Stieb S, Snider JW, Placidi L, et al.
    Int J Rad Onc Biol Phys (2017).
    DOI: 10.1016/j.ijrobp.2017.08.037
  • Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas Tran S, Puric E, Walser M, et al.
    BR J Radiol (2019).
    DOI: 10.1259/bjr.20180883
  • Factors influencing the performance of patient specific quality assurance for pencil beam scanning IMPT fields Trnková P, Bolsi A, Albertini F, et al.
    Med Phys (2016).
    DOI: 10.1118/1.4964449
  • Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates van de Water S, Safai S, Schippers JM, et al.
    Acta Oncol (2019).
    DOI: 10.1080/0284186X.2019.1627416
  • Anatomical robust optimization to account for nasal cavity filling Variation during intensity-modulated proton therapy: a comparison with conventional and adaptive planning strategies van de Water S, Albertini F, Weber DC, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa9c1c
  • Noninvasive eye localization in ocular proton therapy through optical eye tracking: A proof of concept Via R, Hennings F, Fattori G, et al.
    Med Phys (2018).
    DOI: 10.1002/mp.12841
  • Proton therapy for brain tumours in the area of evidence-based medicine Weber DC, Lim PS, Tran S, et al.
    Br J Radiol (2019).
    DOI: 10.1259/bjr.20190237
  • Bringing Europe together in building clinical evidence for proton therapy – the EPTN–ESTRO–EORTC endeavor Weber DC, Grau C, Lim PS, et al.
    Act Oncol (2019).
    DOI: 10.1080/0284186X.2019.1624820
  • Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy Weber DC, Murray FR, Combescure C, et al.
    Radiother Oncol (2018).
    DOI: 10.1016/j.radonc.2018.06.040
  • Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN Weber DC, Habrand JL, Hoppe BS, et al.
    Radiother Oncol (2018).
    DOI: 10.1016/j.radonc.2018.05.020
  • Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) Weber DC, Ares C, Villa S, et al.
    Radiother Oncol (2018).
    DOI: 10.1016/j.radonc.2018.06.018
  • Pencil beam scanned protons for the treatment of patients with Ewing sarcoma Weber DC, Murray FR, Correia D, et al.
    Pediatr Blood Cancer (2017).
    DOI: 10.1002/pbc.26688
  • Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire Weber DC, Murray FR, Correia D, et al.
    Radiother Oncol (2017).
    DOI: 10.1016/j.radonc.2017.07.012
  • Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute Weber DC, Badiyan S, Malyapa R, et al.
    Neuro-Oncol (2016).
    DOI: 10.1093/neuonc/nov154
  • Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy Weber DC, Malyapa R, Albertini F, et al.
    Radiother Oncol (2016).
    DOI: 10.1016/j.radonc.2016.05.011
  • Rhabdoid Tumour of the Orbit in a Child Wilms V, Jaeger M, Schlamann M, et al.
    Klin Monbl Augenheilkd (2019).
    DOI: 10.1055/a-0838-5604
  • Evaluation of the ray-casting analytical algorithm for pencil beam scanning proton therapy Winterhalter C, Zepter S, Shim S, et al.
    Phys Med Biol (2019).
    DOI: 10.1088/1361-6560/aafe58
  • Comment on 'Collimated proton pencil-beam scanning for superficial targets: impact of the order of range shifter and aperture' Winterhalter C, Lomax AJ, Oxley D, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aae0e1
  • Validating a Monte Carlo approach to absolute dose quality assurance for proton pencil beam scanning Winterhalter C, Fura E, Tian Y, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aad3ae
  • Contour scanning, multi-leaf collimation and the combination thereof for proton pencil beam scanning Winterhalter C, Meier G, Oxley D, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aaf2e8
  • Log file based Monte Carlo calculations for proton pencil beam scanning therapy Winterhalter C, Meier G, Oxley D, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aaf82d
  • A study of lateral fall-off (penumbra) optimisation for pencil beam scanning (PBS) Proton therapy Winterhalter C, Lomax AJ, Oxley D, et al.
    Phys Med Biol (2018).
    DOI: 10.1088/1361-6560/aaa2ad
  • Dosimetric uncertainties as a result of temporal resolution in 4D dose calculations for PBS proton therapy Zhang Y, Huth I, Weber DC, et al.
    Phys Med Biol (2019).
    DOI: 10.1088/1361-6560/ab1d6f
  • A statistical comparison of motion mitigation performances and robustness of various pencil beam scanned proton systems for liver tumour treatments Zhang Y, Huth I, Weber DC, et al.
    Radiother Oncol (2018).
    DOI: 10.1016/j.radonc.2018.01.019
  • Surface as a motion surrogate for gated re-scanned pencil beam proton therapy Zhang Y, Huth I, Wegner M, et al.
    Phys Med Biol (2017).
    DOI: 10.1088/1361-6560/aa66c5
  • An evaluation of rescanning technique for liver tumor treatments using a commercial PBS proton therapy system Zhang Y, Huth I, Wegner M, et al.
    Radiother-Oncol (2016).
    DOI: 10.1016/j.radonc.2016.09.011

2011-2015

  • Experimental verification of IMPT treatment plans in an anthropomorphic phantom in the presence of delivery uncertainties Albertini F, Casiraghi M, Lorentini S, Rombi B, Lomax AJ
    Phys Med Biol (2011).
    DOI: 10.1088/0031-9155/56/14/012
  • Is it necessary to plan with safety margins for actively scanned proton therapy? Albertini F, Hug EB, Lomax AJ
    Phys Med Biol (2011).
    DOI: 10.1088/0031-9155/56/14/011
  • Quantifying the impact of respiratory-gated 4D CT acquisition on thoracic image quality: A digital phantom study Bernatowicz K, Keall P, Mishra P, et al.
    Med Phys (2015).
    DOI: 10.1118/1.4903936
  • Advantages and limitations of the "worst case scenario" approach in IMPT treatment planning Casiraghi M, Albertini F, Lomax AJ
    Phys Med Biol (2013).
    DOI: 10.1088/0031-9155/58/5/1323
  • Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale Datta NR, Puric E, Schneider R, et al.
    Int J Hyperthermia (2014).
    DOI: 10.3109/02656736.2014.963703
  • The effect of surgical titanium rods on proton therapy delivered for cervical bone tumors: experimental validation using an anthropomorphic phantom Dietlicher I, Casiraghi M, Ares C, et al.
    Phys Med Biol (2014).
    DOI: 10.1088/0031-9155/59/23/7181
  • Pediatric anesthesia for proton radiotherapy : medicine remote from the medical centre Frei-Welte M, Weiss M, Neuhaus D, et al.
    Anaesthesist (2012).
    DOI: 10.1007/s00101-012-2085-2
  • Experimental validation of beam quality correction factors for proton beams Goma C, Hofstetter-Boillat B, Safai S, Vörös S
    Phys Med Biol (2015).
    DOI: 10.1088/0031-9155/60/8/3207
  • Benchmarking of a treatment planning system for spot scanning proton therapy: Comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningioma Harding R, Trnková P, Weston SJ, et al.
    Med Phys (2014).
    DOI: 10.1118/1.4897571
  • In the context of radiosurgery: Pros and cons of rescanning as a solution for treating moving targets with scanned particle beams Knopf AC, Lomax AJ
    Physica Medica (2014).
    DOI: 10.1016/j.ejmp.2014.03.010
  • Dose-painting intensity-modulated Proton therapy for intermediate- and high-risk meningioma Madani I, Lomax AJ, Albertini F, etc.
    Radiat Oncol (2015).
    DOI: 10.1186/s13014-015-0384-x
  • Defining robustness protocols: a method to include and evaluate robustness in clinical plans McGowan SE, Albertini F, Thomas SJ, Lomax AJ
    Phys Med Biol (2015).
    DOI: 10.1088/0031-9155/60/7/2671
  • Independent dose calculations for commissioning, quality assurance and dose reconstruction of PBS proton therapy Meier G, Besson R, Nanz A, et al.
    Phys Med Biol (2015).
    DOI: 10.1088/0031-9155/60/7/2819
  • Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors Pehlivan B, Ares C, Lomax AJ, et al.
    Int J Rad Onc Biol Phys (2012).
    DOI: 10.1016/j.ijrobp.2011.10.042
  • Proton therapy for uveal melanoma in 43 juvenile patients: long-term results Petrovic A, Bergin C, Schalenbourg A, et al.
    Ophthalmology (2014).
    DOI: 10.1016/j.ophtha.2013.10.032
  • Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at Paul Scherrer Institute Rombi B, Ares C, Hug EB, et al.
    Int J Rad Onc Biol Phys (2013).
    DOI: 10.1016/j.ijrobp.2013.02.026
  • First experimental results of motion mitigation by continuous line scanning of protons Schatti A, Meer D, Lomax AJ
    Phys Med Biol (2014).
    DOI: 10.1088/0031-9155/59/19/5707
  • The effectiveness of combined gating and re-scanning for treating mobile targets with proton spot scanning. An experimental and simulation-based investigation Schatti A, Zakova M, Meer D, et al.
    Phys Med Biol (2014).
    DOI: 10.1088/0031-9155/59/14/3813
  • Experimental verification of motion mitigation of discrete proton spot scanning by re-scanning Schatti A, Zakova M, Meer D, et al.
    Phys Med Biol (2013).
    DOI: 10.1088/0031-9155/58/23/8555
  • Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms Schneider R, Vitolo V, Albertini F, et al.
    Strahlenther Onkol (2013).
    DOI: 10.1007/s00066-013-0432-0
  • Spot-scanning based proton therapy for extracranial chordoma Staab A, Rutz HP, Ares C, et al.
    Int J Rad Onc Biol Phys (2011).
    DOI: 10.1016/j.ijrobp.2011.02.018
  • Dose to the developing dentition during therapeutic Irradiation: organ at risk determination and clinical implications Thompson RF, Schneider RA, Albertini F, et al.
    Int J Rad Onc Biol Phys (2013).
    DOI: 10.1016/j.ijrobp.2012.11.041
  • Tumor control and QoL outcome of very young children with atypical teratoid/rhabdoid Tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy Weber DC, Ares C, Malyapa R, et al.
    J Neurooncol (2015).
    DOI: 10.1007/s11060-014-1648-2
  • Pencil Beam Scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of Patients Treated at the Paul Scherrer Institute Weber DC, Ares C, Albertini F, et al.
    Pediatr Blood Cancer (2015).
    DOI: 10.1002/pbc.25864
  • Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network Weber DC, Wang Y, Miller R, et al.
    Neuro Oncol (2015).
    DOI: 10.1093/neuonc/nou293
  • IMRT credentialing for prospective trials using institutional virtual phantoms: results of a joint European Organization for the Research and Treatment of Cancer and Radiological Physics Center project Weber DC, Vallet V, Molineu A, et al.
    Radiat Oncol (2014).
    DOI: 10.1186/1748-717X-9-123
  • Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer Weber DC, Hurkmans CW, Melidis C, et al.
    Radiother Oncol (2014).
    DOI: 10.1016/j.radonc.2014.04.015
  • Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute Weber DC, Schneider R, Goitein G, et al.
    Int J Rad Onc Biol Phys (2012).
    DOI: 10.1016/j.ijrobp.2011.08.027
  • Improving 4D plan quality for PBS-based liver tumour treatments by combining online image guided beam gating with rescanning Zhang Y, Knopf AC, Weber DC, et al.
    Phys Med Biol (2015).
    DOI: 10.1088/0031-9155/60/20/8141
  • Online image guided tumour tracking with scanned proton beams: a comprehensive simulation study Zhang Y, Knopf A, Tanner C, et al.
    Phys Med Biol (2014).
    DOI: 10.1088/0031-9155/59/24/7793
  • Respiratory liver motion estimation and its effect on scanned proton beam therapy Zhang Y, Boye D, Tanner C, et al.
    Phys Med Biol (2012).
    DOI: 10.1088/0031-9155/57/7/1779

2006-2010

  • The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans Albertini F, Hug EB, Lomax AJ
    Phys Med Biol (2010).
    DOI: 10.1088/0031-9155/55/10/005
  • Sensitivity of intensity modulated proton therapy plans to changes in patient weight Albertini F, Bolsi A, Lomax AJ, et al.
    Radiother Oncol (2008).
    DOI: 10.1016/j.radonc.2007.11.032
  • Postoperative Proton Radiotherapy for Localized and Locoregional Breast Cancer: Potential for Clinically Relevant Improvements? Ares C, Khan S, MacArtain AM, et al.
    Int J Rad Onc Biol Phys (2010).
    DOI: 10.1016/j.ijrobp.2009.02.062
  • Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report Ares C, Hug EB, Lomax AJ, et al.
    Int J Rad Onc Biol Phys (2009).
    DOI: 10.1016/j.ijrobp.2008.12.055
  • Experiences at the Paul Scherrer Institute with a remote patient positioning procedure for high-throughput proton radiation therapy Bolsi A, Lomax AJ, Pedroni E, et al.
    Int J Rad Onc Biol Phys (2008).
    DOI: 10.1016/j.ijrobp.2008.02.079
  • More than 10 years experience of beam monitoring with the Gantry 1 spot scanning proton therapy facility at PSI Lin S, Boehringer T, Coray A, et al.
    Med Phys (2009).
    DOI: 10.1118/1.3244034
  • Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at Paul Scherrer Institute Rutz HP, Weber DC, Goitein G, et al.
    Int J Rad Onc Biol Phys (2008).
    DOI: 10.1016/j.ijrobp.2007.09.014
  • Spot-scanning proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI Timmermann B, Schuck A, Niggli F, et al.
    Strahlenther Onkol (2006).
    DOI: 10.1007/s00066-006-1592-y
  • Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer Institute Timmermann B, Schuck A, Niggli F, et al.
    Int J Rad Onc Biol Phys (2007).
    DOI: 10.1016/j.ijrobp.2006.08.053
  • Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer Institute experience Weber DC, Rutz HP, Bolsi A, et al.
    Int J Rad Onc Biol Phys (2007).
    DOI: 10.1016/j.ijrobp.2007.04.034

2001-2005

  • Eye retention after proton beam radiotherapy for uveal melanoma Egger E, Zografos L, Schalenbourg A, et al.
    Int J Rad Oncol Biol Phys (2003).
    DOI: 10.1016/S0360-3016(02)04200-1
  • Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma Egger E, Schalenbourg A, Zografos L, et al.
    Int J Rad Oncol Biol Phys (2001).
    DOI: 10.1016/S0360-3016(01)01560-7
  • Potential role of intensity-modulated photons and Protons in the Treatment of the breast and regional nodes Lomax AJ, Cella L, Weber D, et al.
    Int J Rad Oncol Biol Phys (2003).
    DOI: 10.1016/S0360-3016(02)04210-4
  • Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of skull base: The Paul Scherrer Institut experience Weber DC, Rutz HP, Pedroni ES, et al.
    Int J Rad Oncol Biol Phys (2005).
    DOI: 10.1016/j.ijrobp.2005.02.023
  • Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas Weber DC, Lomax AJ, Rutz HP, et al.
    Radiother Oncol (2004).
    DOI: 10.1016/j.radonc.2004.02.011

Contact

Paul Scherrer Institute
Center for Proton Therapy
5232 Villigen PSI West, Switzerland
Reception PSI West

For any questions please refer to our patient's office:
Tel: +41 56 310 35 24
Fax: +41 56 310 35 15
E-mail: protonentherapie@psi.ch

Head and Chairman:
Prof. Dr. med.
Damien Charles Weber

Protons for Children

Especially children can profit from treatment with protons

Primo medico

1311121314

Directions to PSI

How to get to the Paul Scherrer Institute (description and map)

Open positions

Current openings at the Center for Proton Therapy.